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Abstract 
Cancer is one of the most deadly and widespread diseases nowadays. Local cancer treatments are gaining strong importance. 
Magnetic Drug Targeting and magnetic heating treatment are minimal invasive cancer treatments that make use of magnetic 
nanoparticles as drug carriers in the first case and to induce heat transfer in the second case. For MDT the application of drugs, 
bound to magnetic nanoparticles, is realized via the tumor supplying vessels while a strong magnetic field gradient influences the 
flow and directs the nanoparticles to the respective region. In order to understand the mechanisms behind this magnetically 
controlled drug delivery, an ex-vivo artery model has been established. To study the amount and the distribution of magnetic 
nanoparticles within the arteries, microcomputed tomography and magnetorelaxometry have been used as analytical techniques. 
MRX provides very sensitively the amount of magnetic nanoparticles, while microcomputed tomography based on a synchrotron 
beam line enables 3-dimensional non-destructive examination of the distribution of the magnetic nanoparticles at a spatial 
resolution of a few micrometers. In this paper we present first results concerning the quantitative study of accumulation of 
nanoparticles within bovine arteries streamed with magnetic nanoparticles. 
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1. Introduction 
Within a DFG (Deutsche Forschungsgemeinschaft) funded project, two different local cancer treatment methods 
are being investigated in order to reduce the side effects generated by the most common cancer treatment therapies, 
chemo- and radiotherapy. These approaches are Magnetic Drug Targeting (MDT) and magnetic heating treatment 
and are based on the use of magnetic nanoparticles [1-10].  
The administration of magnetic nanoparticles into a testing animal during MDT occurs through the tumour 
supplying vessel. The flow phenomena of ferrofluid within biological vessels systems as well as the influence of the 
magnetic field are not fully understood yet. The study of these processes in-situ is very difficult, due to the high 
number of unknown boundary conditions and interactions between particles and blood or lymph. Furthermore, it is 
difficult to treat the animal with MDT and study simultaneously and non-invasively the flow phenomena within the 
artery. It is of great importance to study these processes in order to improve the application of magnetic fluids 
carrying drugs. For this purpose an ex-vivo model can be used to examine the flow phenomena within vessels.  
In this paper we present an ex-vivo artery model rinsed by a physiological medium and ferrofluid, which has been 
attracted by an external magnetic field. To examine the distribution of the nanoparticles within artery tissue, several 
techniques such as magnetorelaxometry and microcomputed tomography have been applied. 
 
2. Experimental 
 
2.1. Ex-vivo artery model 
One of the important stages of MDT is the delivery of the ferrofluid carrying drugs into the tumour region after 
their injection through the supplying vessels. At present a few groups are studying the behaviour of ferrofluids in a 
circuit flow in order to understand the mechanisms of this delivery.  
For these experiments, bovine femoral arteries were streamed by a physiological medium. Ferrofluid was injected 
into the artery following the usual medical protocol for MDT and retained in the central part of the artery by an 
electromagnet. After the flow process finished, the artery was sampled into 11 segments of 10 mm in length each, 
and numbered according to the flow direction ( - 5 for the entry section, ...0 for the middle position, and  +5 for the 
last portion) as shown in FiJ³6HFWLRQ´FRUUHVSRQGVWRWKHUHJLRQZKHUHWKHPDJQHWLFILHOGLVVWURQJHVWGXULQJ
MDT.  
To stabilise the biological tissue for further analysis, the sections were fixed with formalin and embedded in 
paraffin. The concentration and accumulation of magnetic nanoparticles within the arteries have been analysed by 
magnetorelaxometry (MRX) and micro computed tomography (µCT) [11-15]. The latter provides the 3-dimensional 
distribution of magnetic nanoparticles within the artery samples, while with MRX the iron content within the tissue 
samples is quantified in a sensitive way [16-19]. 
 
3. Results and Discussion 
 
3.1. Magnetorelaxometry measurements 
 
Magnetorelaxometry (MRX) is a very sensitive technique to quantify the iron content within a sample. In this 
study the MRX measurements were performed with a single-channel superconducting quantum interference device 
(SQUID) gradiometer. The assessed absolute iron mass within artery No. 1, where the stream was pumped, ranges 
between 2.2(3) µg and 27.5(3) µg. In artery No. 2, where the flow was drawn, the determined absolute iron mass 
range from 2.9(3) µg to 106.9(3) µg.  
3.2. Synchrotron microcomputed tomography 
The extremely high intensity of monochromatic synchrotron radiation gives the opportunity to obtain almost 
noise-free tomographic data sets, and in combination with adequate detector systems, data sets with a very high 
spatial resolution down to a few micrometers. In case of monochromatic radiation the attenuation coefficient µ 
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depends only on the atomic composition and the densities within the sample. This fact allows a quantitative 
evaluation of the data. 
 In this study the tomographic examination of the biological tissue samples was performed on the equipment 
operated by GKSS, at BW2-beamline at DESY (Deutsches Elektronen Synchrotron) in Hamburg/Germany using a 
photon energy of 17 keV and an optical magnification of 2.5 resulting in a pixel size of 4.5 µm².  
 
  
Fig. 1: Cross-section of tomographic rendered representations of bovine artery No. 1, Section 1 and Section -5. 
 
A tomographic scan is recorded in grey scale images. These grey values are directly connected to the absorption 
of the X-rays depending on the composition and densities inside the object. A low grey value corresponds to minor 
absorption, hence to lower densities, and a high grey value corresponds to the maximum absorption, and therefore to 
the most dense materials within the sample.  
These samples consist mainly of three components: magnetic nanoparticles, biological tissue and paraffin, where 
the sample is embedded.  
During the digital image processing the histograms of the data sets have been analysed. In the histogram the grey 
values are plotted as a function of their intensity (number of pixels for each grey value).  
As mentioned before the grey values are correlated to the absorption of the X-rays, which depends on the 
densities and composition within the sample. Therefore the histogram can be used to separate the different 
components of the tomographic data set of the artery segment. For the segmentation the three peaks in the histogram 
have been fitted with Gaussian curves and the intersection points have been determined.  These intersection points 
define the position of the thresholds which have been used to separate the main components of the samples. The 
orange marked curve represents the paraffin fixating the sample; the highest peak is labelled yellow and represents 
biological tissue, and finally the red coloured curve represents the highest density within the sample ± the magnetic 
nanoparticles inside the artery segments. This peak corresponds to the red areas in Fig. 1. Therefore, we can see 
where the nanoparticles accumulate. 
The examinations with MRX have shown that the quantity of magnetic nanoparticles deposited in the artery is 
enhanced near the tip of the magnet. Accordingly, the regions far away from the magnetic tip have minor uptake of 
magnetic nanoparticles. The tomography results agree with the MRX results. In section 1 (see Fig. 1), where the 
amount of iron measured with MRX is the highest (see Fig. 2), the tomographic rendered data shows a big plug of 
nanoparticles blocking the vessel plus some nanoparticles accumulated in the inner walls. In section -5 (see Fig. 5), 
far away from the highest field strength, where MRX gives the lowest amount of iron, only a minor enrichment of 
magnetic nanoparticles within the inner walls was detected by µCT. 
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4. Conclusion 
 
The combination of MRX and SRµCT provides important information for better understanding of the directed 
ferrofluid delivery process during MDT. The main points are listed beneath. 
The magnetic field gradient has a strong influence on the distribution and amount of nanoparticles accumulated 
within the vessel. 
Far away from the point of highest magnetic field strength, the nanoparticles accumulate at the inner walls of the 
artery. 
Where the intensity of the magnetic field is strongest, the nanoparticles not only accumulate at the inner walls of 
the artery, but also block the vessel. 
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